MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41551-026-01614-w

Медицинская библиотека · Nature biomedical engineering · 2026

DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases.

Zeng Yang C, Young Olivia J, Xiong Qiancheng, Si Longlong, Ku Min Wen, Bernier Sylvie G, Dembele Hawa, Isinelli Giorgia, Gilboa Tal, Swank Zoe, Seok Su Hyun, Rajwar Anjali, Jiang Amanda, Zhai Yunhao, Williams LaTonya D, Hellman Caleb A, Wintersinger Chris M, Graveline Amanda R, Vernet Andyna, Sanchez Melinda, Bardales Sarai, Tomaras Georgia D, Ryu Ju Hee, Kwon Ick Chan, Goyal Girija, Ingber Donald E, Shih William M

СтатьяПеревод пока не подготовлен

Аннотация

Current SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccines have shown robust induction of neutralizing antibodies and CD4+ T cell activation; however, CD8+ responses are variable, and the duration of immunity and protection against variants are limited. Here we repurpose our DNA origami vaccine nanotechnology DoriVac to target infectious viruses, namely, SARS-CoV-2, HIV and Ebola. The DNA origami nanoparticle, conjugated with infectious-disease-specific heptad repeat 2 peptides, which act as highly conserved antigens, and CpG adjuvant at precise nanoscale spacing, induces neutralizing antibodies, Th1 CD4+ T cells and CD8+ T cells in naive mice, with significant improvement over a bolus control. Pre-clinical studies using lymph-node-on-a-chip systems validate that DoriVac, when conjugated with antigenic peptides or proteins, induces promising cellular and humoral immune responses in human cells. Moreover, DoriVac bearing full-length SARS-CoV-2 spike protein achieves immune responses comparable to current mRNA vaccine platforms while potentially reducing storage constraints. These results suggest that DoriVac holds potential as a versatile, modular vaccine platform, capable of inducing both humoral and cellular immunities, underscoring its potential future use.

Для цитирования: Zeng Yang C, Young Olivia J, Xiong Qiancheng, Si Longlong, Ku Min Wen, Bernier Sylvie G, Dembele Hawa, Isinelli Giorgia, Gilboa Tal, Swank Zoe, Seok Su Hyun, Rajwar Anjali, Jiang Amanda, Zhai Yunhao, Williams LaTonya D, Hellman Caleb A, Wintersinger Chris M, Graveline Amanda R, Vernet Andyna, Sanchez Melinda, Bardales Sarai, Tomaras Georgia D, Ryu Ju Hee, Kwon Ick Chan, Goyal Girija, Ingber Donald E, Shih William M. DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases.. Nature biomedical engineering. 2026. DOI: 10.1038/s41551-026-01614-w.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.